APA-referens

Li, X., Liu, M., Zhang, H., Liu, H., & Chen, J. (2020). Clinical study of apatinib combined with EGFR‐TKI in the treatment of chronic progression after EGFR‐TKI treatment in non‐small cell lung cancer (ChiCTR1800019185). Thorac Cancer.

Chicago-stil citat

Li, Xin, Minghui Liu, Hongbing Zhang, Hongyu Liu, och Jun Chen. "Clinical Study of Apatinib Combined With EGFR‐TKI in the Treatment of Chronic Progression After EGFR‐TKI Treatment in Non‐small Cell Lung Cancer (ChiCTR1800019185)." Thorac Cancer 2020.

MLA-referens

Li, Xin, et al. "Clinical Study of Apatinib Combined With EGFR‐TKI in the Treatment of Chronic Progression After EGFR‐TKI Treatment in Non‐small Cell Lung Cancer (ChiCTR1800019185)." Thorac Cancer 2020.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.